Top 10 Medical Stocks To Own Right Now

Medibloc prices surged 123% over the last 24 hours as traders continued to pile money into alternatives coins.

Medibloc isn’t a household name, but it was today’s top performer in the space. While it’s unclear why prices skyrocketed, the crypto startup has been generating buzz before the gains.

Forbes reported on advancements of South Korean startups in a Jan. 3 report and highlighted Medibloc as a startup to watch.

The project aims to streamline the medical-record business by putting customer data on a blockchain, where it can be transferred easier and more securely.

Top 10 Medical Stocks To Own Right Now: Genuine Parts Company(GPC)

Advisors’ Opinion:

  • [By ]

    After delivering 9% (including dividends) since my recommendation, shares of Genuine Parts Co. (NYSE: GPC) now trade at an attractive 15% discount to their 52-week high. Despite the rise and sudden drop, my original investment thesis is still intact.

  • [By Lee Samaha]

    Genuine Parts Company (NYSE:GPC), owner of NAPA Auto Parts, became the first of the major auto parts companies to report earnings and sales for its first-quarter period ending on March 21.

  • [By WWW.MONEYSHOW.COM]

    Aflac (AFL) — yielding 2.5%
    Archer-Daniels Midland (ADM) — yielding 2.7%
    Chevron (CVX) — yielding 3.8%
    ExxonMobil (XOM) — yielding 3.6%
    Genuine Parts (GPC) — yielding 2.7%
    Johnson & Johnson (JNJ) — yielding 2.8%
    T. Rowe Price (TROW) — yielding 3.2%

  • [By ]

    2. Price To Sales
    Another useful metric is the price-to-sales ratio (P/S). P/S measures a company’s market cap versus its annual revenue number. The idea is that the lower the number, the greater the implied value. For example, Snap, Inc. (Nasdaq: SNAP) trades at 26.9 times sales, an incredibly expensive number. However, aftermarket auto parts giant Genuine Parts (NYSE: GPC) trades at just 0.88 times sales — 88 cents to every dollar of sales the company brings in. Often, the lower the number, the more inefficiently the market has mispriced the stock.

Top 10 Medical Stocks To Own Right Now: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

  • [By Jack Delaney]

    Some of the most well-known dividend aristocrats include:

    Exxon Mobil Corp. (NYSE: XOM) pays a dividend of $0.77, which is a yield of 3.75%. Aflac Inc. (NYSE: AFL) pays a dividend of $0.43, which is a yield of 2.32%. AT&T Inc. (NYSE: T) pays a dividend of $0.49, which is a yield of 5.12%. T-Rowe Price Group Inc. (Nasdaq: TROW) pays a dividend of $0.57, which is a yield of 3.27%. Clorox Co. (NYSE: CLX) pays a dividend of $0.84, which is a yield of 2.50%.

    If you just kept the dividends, your investment would be worth $11,147. That’s a difference of only $25. So it may not seem like a big deal at first glance.

Top 10 Medical Stocks To Own Right Now: M&T Bank Corporation(MTB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Top 10 Medical Stocks To Own Right Now: G&K Services, Inc.(GK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We maintain our positive view toward Cintas, particularly as G&K Services (GK) is likely to bolster Cintas’s growth potential over the next few years. However, after strong appreciation since the G&K announcement last August, we believe that much of the good news is already priced in at 25x/22x our pro-forma FY18/FY19 adjusted EPS estimates. As a result, we rate CTAS Sector Perform and await a better entry point.

  • [By Ben Levisohn]

    Cintas (CTAS) soared to the top of the S&P 500 today after the uniform provider received the go-ahead for its purchase of G&K Services (GK).

Top 10 Medical Stocks To Own Right Now: Daktronics, Inc.(DAKT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Daktronics, Inc. (NASDAQ: DAKT) is projected to report its quarterly earnings at $0.08 per share on revenue of $156.17 million.

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

  • [By Monica Gerson]

    Daktronics, Inc. (NASDAQ: DAKT) is estimated to report its quarterly earnings at $0.08 per share on revenue of $156.17 million. Daktronics shares slipped 0.13 percent to close at $7.97 on Tuesday.

Top 10 Medical Stocks To Own Right Now: LeMaitre Vascular, Inc.(LMAT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares rose by just 0.6 percent. Meanwhile, top losers in the sector included LeMaitre Vascular Inc (NASDAQ: LMAT), down 5 percent, and pSivida Corp. (NASDAQ: PSDV), down 3 percent.

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top 10 Medical Stocks To Own Right Now: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid treatment has become an elusive target. And it’s too bad when you consider how many people have become addicted to opioids in America.

  • [By Chris Lange]

    Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) has announced preliminary unaudited total revenues and net product sales for Exparel for the fourth quarter and the full year. Total revenues were $72.9 million and $276.4 million for the fourth quarter and full year, respectively. Exparel net product sales were $71.4 million and $239.9 million for the same periods, respectively. The consensus estimates from Thomson Reuters were calling for revenues of $72.56 million in the fourth quarter and $276.09 million in the full year.

  • [By Lisa Levin]

    Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares were also up, gaining 17 percent to $39.80. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.

Top 10 Medical Stocks To Own Right Now: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotech RXi Pharmaceuticals Corp (NASDAQ: RXII) as a long/bullish trade for our short-term portfolio:

Top 10 Medical Stocks To Own Right Now: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 3.8% Thursday to post a new 52-week low of $2.28. Shares closed at $2.37 on Wednesday and the stock’s 52-week high is $4.25. Volume was about 15% below the daily average of around 5.9 million shares. The company had no specific news.

Top 10 Medical Stocks To Own Right Now: Toro Company (The)(TTC)

Advisors’ Opinion:

  • [By Mitchell Clark]

     The Toro Company (NYSE:TTC) is one of my favorite small-caps for medium- to long-term investors. Selling specialized equipment for turf management and other industries, Toro is a proven winner that has provided very consistent growth in sales and earnings over the years.

    It’s not the fastest growing small-cap business, but it pays a decent dividend and has a loyal customer base in the golf course and contractor markets.

    Toro is now offering sprinkler refit equipment for water-starved jurisdictions like California. This company’s share price performance has been exemplary.

  • [By WWW.THESTREET.COM]

    In his “Homework” segment, Cramer followed up on a few stocks that had stumped him during earlier shows. He said that he’s taking a pass on Toro (TTC) , a stock that’s just off its highs and trades at a premium to rival Deere & Company (DE) .